Daniel Lee Flynn, Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 244,408 shares at $26.00 ($4.0M) on 2019-01-16, disclosed to the SEC on 2019-01-18.
Open-market sale of $4.0M DCPH by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 91,779 | $0 | 0.0% |
| 2 | $26.00 | 152,629 | $4.0M | 100.0% |
| Total | $16.24 avg | 244,408 | $4.0M | 100% |
| Filing → |
| DCPH | SELL | 2023-01-19 | $102K | — | Filing → |
| DCPH | SELL | 2022-06-21 | $19K | — | Filing → |
| DCPH | SELL | 2022-02-18 | $12K | — | Filing → |